Switch from aprotinin to ε-aminocaproic acid: Impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery

Keyphrases

• Neonate 100%
• Blood Loss 100%
• Cardiac Surgery 100%
• Aprotinin 100%
• Aminocaproic Acid 100%
• Clinical Outcomes 100%
• Transfusion Outcomes 100%
• In-hospital Mortality 50%
• Transfusion Requirements 50%
• High Risk 25%
• Therapeutic Regimen 25%
• Transfusion 25%
• Vascular Events 25%
• Neurological Complications 25%
• Vascular Complications 25%
• Extracorporeal Circulation 25%
• Neurological Events 25%
• Sparing Effect 25%
• Intraoperative Blood Loss 25%
• Antifibrinolytics 25%
• Reoperation for Bleeding 25%
• Renal Vascular 25%
• Renal Complications 25%
• Renal Events 25%
• Hyperfibrinolysis 25%
• Neonatal Patients 25%
• Perioperative Data 25%

Nursing and Health Professions

• Neonate 100%
• Clinical Outcome 100%
• Heart Surgery 100%
• Bleeding 100%
• Aprotinin 100%
• Aminocaproic Acid 100%
• Hospital Mortality 33%
• Perioperative 16%
• Antifibrinolytic Agent 16%
• Side Effect 16%
• Extracorporeal Circulation 16%
• Reoperation 16%
• Postoperative Hemorrhage 16%
• Neurological Complication 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleeding 100%
• Aminocaproic Acid 100%
• Aprotinin 100%
• Hospital Mortality 33%
• Side Effect 16%
• Antifibrinolytic Agent 16%
• Neurological Complication 16%
• Postoperative Hemorrhage 16%